Chemoinformaics analysis of ISOLONGIFOLENE, 4,5-DEHYDRO-
| Molecular Weight | 202.341 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 202.172 | nRing | 3 |
| Solubility: LogS | -5.664 | nHRing | 0 |
| Solubility: LogP | 5.185 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.7194 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.513 |
| Synth | 5.803 |
| Natural Product Likeliness | 2.317 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.025 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.446 |
| MDCK | 0.0000149 |
| BBB | 0.119 |
| PPB | 0.955807 |
| VDSS | 2.425 |
| FU | 0.0575384 |
| CYP1A2-inh | 0.23 |
| CYP1A2-sub | 0.847 |
| CYP2c19-inh | 0.702 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.503 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.127 |
| CYP2d6-sub | 0.699 |
| CYP3a4-inh | 0.692 |
| CYP3a4-sub | 0.411 |
| CL | 4.936 |
| T12 | 0.038 |
| hERG | 0.002 |
| Ames | 0.006 |
| ROA | 0.11 |
| SkinSen | 0.022 |
| Carcinogencity | 0.581 |
| EI | 0.949 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.945 |
| Antiviral | Yes |
| Prediction | 0.881598 |